[1] |
CZŁONKOWSKA A, LITWIN T, DUSEK P, et al. Wilson disease[J]. Nat Rev Dis Primers, 2018, 4(1): 21. DOI: 10.1038/s41572-018-0018-3
|
[2] |
GITLIN JD. Wilson disease[J]. Gastroenterology, 2003, 125(6): 1868-1877. DOI: 10.1053/j.gastro.2003.05.010
|
[3] |
ZHONG HJ, SUN HH, XUE LF, et al. Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis[J]. World J Gastroenterol, 2019, 25(3): 378-387. DOI: 10.3748/wjg.v25.i3.378
|
[4] |
MERLE U, SCHAEFER M, FERENCI P, et al. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: A cohort study[J]. Gut, 2007, 56(1): 115-120. DOI: 10.1136/gut.2005.087262
|
[5] |
BRUHA R, MARECEK Z, POSPISILOVA L, et al. Long-term follow-up of Wilson disease: Natural history, treatment, mutations analysis and phenotypic correlation[J]. Liver Int, 2011, 31(1): 83-91. DOI: 10.1111/j.1478-3231.2010.02354.x
|
[6] |
ROCKEY DC, CALDWELL SH, GOODMAN ZD, et al. Liver biopsy[J]. Hepatology, 2009, 49(3): 1017-1044. DOI: 10.1002/hep.22742
|
[7] |
SIDDIQUI MS, YAMADA G, VUPPALANCHI R, et al. Diagnostic accuracy of noninvasive fibrosis models to detect change in fibrosis stage[J]. Clin Gastroenterol Hepatol, 2019, 17(9): 1877-1885. DOI: 10.1016/j.cgh.2018.12.031
|
[8] |
MARELLA HK, REDDY YK, JIANG Y, et al. Accuracy of noninvasive fibrosis scoring systems in African American and white patients with nonalcoholic fatty liver disease[J]. Clin Transl Gastroenterol, 2020, 11(4): e00165. DOI: 10.14309/ctg.0000000000000165
|
[9] |
SCHMOYER CJ, KUMAR D, GUPTA G, et al. Diagnostic accuracy of noninvasive tests to detect advanced hepatic fibrosis in patients with hepatitis C and end-stage renal disease[J]. Clin Gastroenterol Hepatol, 2020, 18(10): 2332-2339. DOI: 10.1016/j.cgh.2020.02.019
|
[10] |
PATERNOSTRO R, PFEIFFENBERGER J, FERENCI P, et al. Non-invasive diagnosis of cirrhosis and long-term disease monitoring by transient elastography in patients with Wilson disease[J]. Liver Int, 2020, 40(4): 894-904. DOI: 10.1111/liv.14368
|
[11] |
SINI M, SORBELLO O, CIVOLANI A, et al. Non-invasive assessment of hepatic fibrosis in a series of patients with Wilson's Disease[J]. Dig Liver Dis, 2012, 44(6): 487-491. DOI: 10.1016/j.dld.2011.12.010
|
[12] |
European Association for Study of Liver. EASL clinical practice guidelines: Wilson's disease[J]. J Hepatol, 2012, 56(3): 671-685. DOI: 10.1016/j.jhep.2011.11.007
|
[13] |
BEDOSSA P, POYNARD T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group[J]. Hepatology, 1996, 24(2): 289-293. DOI: 10.1002/hep.510240201
|
[14] |
FERENCI P, STREMMEL W, CZŁONKOWSKA A, et al. Age and sex but not ATP7B genotype effectively influence the clinical phenotype of Wilson disease[J]. Hepatology, 2019, 69(4): 1464-1476. DOI: 10.1002/hep.30280
|
[15] |
SOKOL RJ, TWEDT D, MCKIM JM Jr, et al. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis[J]. Gastroenterology, 1994, 107(6): 1788-1798. DOI: 10.1016/0016-5085(94)90822-2
|
[16] |
CROSAS-MOLIST E, FABREGAT I. Role of NADPH oxidases in the redox biology of liver fibrosis[J]. Redox Biol, 2015, 6: 106-111. DOI: 10.1016/j.redox.2015.07.005
|
[17] |
ZISCHKA H, LICHTMANNEGGER J. Pathological mitochondrial copper overload in livers of Wilson's disease patients and related animal models[J]. Ann N Y Acad Sci, 2014, 1315: 6-15. DOI: 10.1111/nyas.12347
|